RecruitingBrain Metastases
MeDex: No Perioperative Dexamethasone in Brain Metastases
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Perioperative treatment of newly diagnosed cancer patients with brain metastasis without dexamethasone (Dex).
Sponsor: University of Louisville
You may qualify if…
- ✓ 1. New brain tumor(s) on imaging
- ✓ 2. Visceral mass(es) suspicious or confirmed for neoplasm
- ✓ a. Patients with lung mass suspicious for primary lung cancer and no prior diagnosis must undergo biopsy of the lung mass prior to resection of brain metastasis(es) to exclude histology (i.e., small cell lung carcinoma) that would not benefit from resection
- ✓ 3. No contraindications for craniotomy
- ✓ 4. Age ≥ 18 years
- ✓ 5. ECOG performance status ≤ 2 (i.e., ambulatory \> 50% of waking hours)
- ✓ 6. Midline shift on MRI ≤ 10 mm
- ✓ 7. Craniotomy planned to resect \>75% of the enhancing mass (surgeon's judgment)
You may not qualify if…
- ✕ 1. Presence of BMs not eligible for resection that are each \> 2 cm in any one dimension
- ✕ 2. \>4 BMs not eligible for resection that are each 2 cm in any one dimension
- ✕ 3. Treatment with laser interstitial thermal therapy (LITT)
- ✕ 4. High concern for primary CNS lymphoma
- ✕ 5. Diagnosis of small cell lung carcinoma
- ✕ 6. Any receipt of Dex
- ✕ 7. Steroid use in the past month
- ✕ 8. A condition that requires steroids
Where it's recruiting
Kentucky
Louisville
Source: ClinicalTrials.gov · NCT07044557 · last updated 2026-05-29